shopify traffic stats

Recent Press Releases

ContraVir in the Media

BIO Launces DrugCostFacts.org

By | Industry News
What is biotechnology? At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. We have used the biological processes of microorganisms for more than 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products. Modern biotechnology provides breakthrough products and technologies to combat debilitating and rare...
Read More

Biotechnology: Saving Lives & Transforming Healthcare in the 21st Century

By | Industry News
Modern biotechnology is a young industry. But in just a few decades, the entrepreneurs, scientists, researchers and investors working in this field have firmly established themselves at the forefront of medical innovation. Their work is transforming the way we treat – and now even cure – patients with a wide range of once-devastating diseases. And these visionaries are only getting started. All across the country today, there is work being done in labs that, if successful,...
Read More

BioSurplus Appoints Theresa Matkovits, Ph.D. to its Board of Directors

By | Media Placements
Theresa Matkovits, Ph.D., ContraVir’s Senior Vice President, Drug Development, has been appointed to the Board of Directors at BioSurplus, America’s preeminent buyer and reseller of preowned lab equipment. Her appointment to the BioSurplus board follows her recent participation in Women in Bio’s first Boardroom Ready Class. “The knowledge that Dr. Matkovits brings to our board will be incredibly valuable as we continue to expand our offerings to life science companies and universities,” said Bill VanDeWeghe,...
Read More

Media Contact

JFK Communications

Contact: Kaitlin Newingham
Telephone: (609) 385-0773
Email: knewingham@jfkhealth.com